Provided by Tiger Trade Technology Pte. Ltd.

ALX Oncology Holdings

1.99
-0.0500-2.45%
Volume:128.24K
Turnover:253.30K
Market Cap:275.17M
PE:-1.73
High:2.03
Open:2.03
Low:1.95
Close:2.04
52wk High:2.66
52wk Low:0.9600
Shares:138.28M
Float Shares:94.74M
Volume Ratio:0.40
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1500
EPS(LYR):-1.9000
ROE:-80.65%
ROA:-40.40%
PB:2.02
PE(LYR):-1.05

Loading ...

ALX Oncology Reports Inducement Grant as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Apr 18

ALX Oncology names Jeff Knight chief development and operating officer

Reuters
·
Apr 13

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

THOMSON REUTERS
·
Apr 13

ALX Oncology Holdings, Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $5

THOMSON REUTERS
·
Mar 19

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation

TIPRANKS
·
Mar 11

ALX Oncology FY2025 net loss narrows 25% to USD 101.7 million

Reuters
·
Mar 10

ALX Oncology Holdings Inc. Files Initial Beneficial Ownership Statement for Chief Medical Officer Barbara Klencke

Reuters
·
Mar 06

ALX Oncology Holdings Q4 Adj. EPS $(0.37) Misses $(0.36) Estimate

Benzinga Earnings
·
Feb 27

ALX Oncology Q4 loss narrows, names permanent CMO

Reuters
·
Feb 27

ALXO Q4 net loss USD 22.8 million (-21.7%)

Reuters
·
Feb 27

BRIEF-ALX Oncology Q4 Basic EPS USD -0.42

Reuters
·
Feb 27

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Feb 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

ALX Oncology Holdings Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Feb 25

ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 19

Press Release: ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

Dow Jones
·
Feb 19